MyFinsight
Home
Blog
About
Contact
Download
Download image
United States
Government
$300,200K
Non United States
Government
$156,500K
Non United States
Government
$223,300K
United States
Government
$2,800K
United States
Government
$36,700K
Non United States
Government
$23,400K
Medical
Countermeasures MCMProduct
$456,700K
Commercial Product
$226,100K
All Other Revenue
$60,100K
Total revenues
$742,900K
(-28.81%↓ Y/Y)
Income (loss) from
operations
$100,100K
(192.09%↑ Y/Y)
Total operating
expenses
$642,800K
(-44.22%↓ Y/Y)
Income (loss) before
income taxes
$82,800K
(157.94%↑ Y/Y)
Total other income
(expense), net
-$17,300K
(49.42%↑ Y/Y)
Other, net
$54,200K
(333.60%↑ Y/Y)
Cost of product and
services sales, net
$326,200K
(75.47%↑ Y/Y)
Selling, general and
administrative
$186,100K
(-69.79%↓ Y/Y)
Amortization of intangible
assets
$65,100K
(0.00%↑ Y/Y)
Research and development
$53,200K
(-24.75%↓ Y/Y)
Impairment of long-lived
assets
$12,200K
(-92.52%↓ Y/Y)
Net income (loss)
$52,600K
(127.60%↑ Y/Y)
Income tax provision
$30,200K
(-36.69%↓ Y/Y)
Interest expense
$59,300K
(-16.48%↓ Y/Y)
Gain (loss) on
extinguishments of debt
-$12,200K
Back
Back
Income Statement
source: myfinsight.com
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS)